As 2023 comes to a close, we’re asking all of our supporters to remember those children who they hold so close to their hearts, and to help us light up the lab by paying tribute to them with a year-end, tax-deductible contribution.
May 19, 2022 - The DIPG Advocacy Group continues to ask congress to help raise awareness for DIPG by asking them to name May 17 National DIPG Awareness Day.
May 1, 2022 - May is brain tumor awareness month and it is represented by the color gray. Please help us raise awareness.
May 3, 2022 - Our team is proud to join the National Brain Tumor Society as they Head to the Hill to advocate for change.
May 1, 2022 - May is brain tumor awareness month and it is represented by the color gray. Please help us raise awareness.
As 2021 comes to a close, we’re asking all of our supporters to remember those children who they hold so close to their hearts, and to help us light up the lab by paying tribute to them with a year-end, tax-deductible contribution.
As 2020 comes to a close, we’re asking all of our supporters to remember those children who they hold so close to their hearts, and to help us light up the lab by paying tribute to them with a year-end, tax-deductible contribution.
JOIN OUR COMMITTEE The greatest gift you can give is hope. This is a very challenging climate for fundraising, and our lab is in a vulnerable position. We need to explore new ways to support our research initiatives, so we have been pulling together a passionate and dedicated Virtual Fundraising Committee. From wine
Donate in Memory of Carolyn Byington Carolyn Byington, 26, was a beloved patient of Dr. Mark Souweidane. He successfully treated her for Chiari malformation in 2008, and he remembers her and her family fondly to this day. Carolyn tragically passed away on June 10, and her family would like to support
PATIENT CARE The Children’s Brain Tumor Project Team is comprised of past and present patient families, biomedical researchers and neurosurgical clinicians working together to find a cure for pediatric brain cancers. The success of the team primarily rests in the transparency that exists between each of these three groups. Clinicians and researchers
